Óxido nítrico y dolor
| dc.contributor.author | López Jaramillo, Patricio | spa |
| dc.contributor.cvlac | López Jaramillo, Patricio [0000043290] | spa |
| dc.contributor.googlescholar | López Jaramillo, Patricio [PDPvKz0AAAAJ&hl=es&oi=ao] | spa |
| dc.contributor.orcid | López Jaramillo, Patricio [0000-0002-9122-8742] | spa |
| dc.date.accessioned | 2020-10-27T14:22:44Z | |
| dc.date.available | 2020-10-27T14:22:44Z | |
| dc.date.issued | 2001-04-11 | |
| dc.description.abstract | Una serie de estudios sugieren que el óxido nítrico (ON)participa de alguna manera en el proceso de nocicepción,por lo que se propuso que alteraciones en su producciónparticiparían en la modulación del dolor, abriendo laposibilidad de que manipulaciones en la vía L-arginina: ON:GMPc podrían ser útiles en el tratamiento de diferentesestados de dolor. La complejidad de los mecanismos queparticipan en la regulación de la expresión genética de lasdiferentes enzimas que constituyen la familia de los óxidonítrico sintasas, la producción cuantitativa diferenciada delON, dependiente de la enzima y de la célula donde segenera, así como la diferente respuesta de las neuronasexcitatorias o inhibitorias ante el ON, ha determinado queno se tenga bien definido el papel exacto del ON en losdiferentes estados de dolor. Además, la gran cantidad de estímulos, las diferentes interacciones de estos y la intensidad de los mismos determina que en la regulación del dolor participen e interactúen una variedad de mecanismos que dependen, aparte de la infinidad de estímulos, de otras condiciones asociadas a la enfermedad de base que ocasiona el dolor. En la presente revisión se discute sobre las vías enzimáticas que conducen a la síntesis de ON, así como el eventual papel que tiene el ON en los modelos experimentales y en situaciones clínicas asociadas con dolor. Queda mucho campo por explorar y que para definir el papel del ON en el dolor son necesarias más investigaciones básicas y aplicadas. La definición de los papeles del ON permitirá abordajes terapéuticos efectivos a través de manipulaciones en la vía L-arginina: ON | spa |
| dc.description.abstractenglish | A series of studies suggest that nitric oxide (NO) participates in some way in the nociception process, so it was proposed that alterations in its production would participate in the modulation of pain, opening the possibility that manipulations in the L-arginine pathway: ON:cGMP could be useful in the treatment of different pain states. The complexity of the mechanisms that participate in the regulation of the genetic expression of the different enzymes that constitute the family of nitric oxide synthases, the differentiated quantitative production of NO, dependent on the enzyme and the cell where it is generated, as well as the different response of excitatory neurons or inhibitory to NO, has determined that the exact role of NO in different pain states is not well defined. Furthermore, the large number of stimuli, their different interactions and their intensity determines that a variety of mechanisms participate and interact in the regulation of pain that depend, apart from the infinite number of stimuli, on other conditions associated with the disease. basis that causes pain. In the present review, the enzymatic pathways that lead to NO synthesis are discussed, as well as the eventual role that NO has in experimental models and in clinical situations associated with pain. There remains a lot of field to explore and more basic and applied research is necessary to define the role of NO in pain. Defining the roles of NO will allow effective therapeutic approaches through manipulations in the L-arginine pathway: NO | eng |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga UNAB | spa |
| dc.identifier.issn | 2382-4603 | |
| dc.identifier.issn | 0123-7047 | |
| dc.identifier.repourl | repourl:https://repository.unab.edu.co | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12749/10588 | |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad Autónoma de Bucaramanga UNAB | |
| dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
| dc.publisher.program | Pregrado Medicina | spa |
| dc.relation | https://revistas.unab.edu.co/index.php/medunab/article/view/322/303 | |
| dc.relation.references | Moncada S, López-Jaramillo P. Actividad biológica del endoteliovascular. Investigación y Ciencia 1991; 176:60-6 | spa |
| dc.relation.references | Moncada S, Higgs EA, Hodson HF, et al. The L-arginine:Nitricoxide pathway. J Cardiovas Pharmacol 1991; 17(Suppl.3):S1-S9 | spa |
| dc.relation.references | López-Jaramillo P. Bioquímica del endotelio vascular:Implicaciones fisiológicas y clínicas. Quinta Edición. HorizonteImpresores, Bogotá, 2001 | spa |
| dc.relation.references | López-Jaramillo P, González MC, Palmer RMJ, Moncada S. Thecrucial role of physiological Ca2+ concentrations in the productionof endothelial nitric oxide and the control of vascular tone. Br JPharmacol 1990; 101:489-93 | spa |
| dc.relation.references | Berrazueta JR, López-Jaramillo P, Moncada S. El óxido nítriceira SH. Blockade of the peripheral pain sensory system via theL-arginine: nitric oxide: cyclic GMP pathway. En: Biology of nitricoxide 1992; 258-60 | spa |
| dc.relation.references | Duarte IDG, Ferreira SH. The molecular mechanism of centralanalgesia induced by morphine or carbachol and the L-arginine-Nitric oxide-cGMP pathway. Eur J Pharmacol 1992; 221:171-4 | spa |
| dc.relation.references | Duarte IDG, Santos IR, Lorenzetti BB, Ferreira SH. Analgesia bydirect antagonism of nociceptor sensitization involves theargenine-nitric oxide cGMP pathway. Eur J Pharmacol 1992;217:225-7 | spa |
| dc.relation.references | Ferreira SH, Duarte IDG, Lorenzetti BB. The molecular mechanismof action of peripheral morphine alagesia: stimulation of cGMPsystem via nitric oxide release. Eur J Pharmacol 1991; 201:121 | spa |
| dc.relation.references | Ferreira SH, Lorenzetti BB, Faccioli LH. Blockade of hyperalgesiaand neurogenic oedema by topical application of nitroglycerin anitric oxide generator. Eur J Pharmacol 1992; 217:207-9 | spa |
| dc.relation.references | Ferreira SH, Duarte IDG. Is the molecular mechanism of centralmorphine analgesia due to activation of the nitric oxide: cyclicGMP pathway via a non-argininergic pathway? En: Biology ofnitric oxide 1992; 316-7 | spa |
| dc.relation.uri | https://revistas.unab.edu.co/index.php/medunab/article/view/322 | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.creativecommons | Atribución-NoComercial-SinDerivadas 2.5 Colombia | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
| dc.source | MedUNAB; Vol. 4 Núm. 10 (2001): Edición especial dolor; 31-37 | |
| dc.subject | Ciencias biomédicas | |
| dc.subject | Ciencias de la vida | |
| dc.subject | Innovaciones en salud | |
| dc.subject | Investigaciones | |
| dc.subject.keywords | Health Sciences | eng |
| dc.subject.keywords | Medicine | eng |
| dc.subject.keywords | Medical Sciences | eng |
| dc.subject.keywords | Biomedical Sciences | eng |
| dc.subject.keywords | Life Sciences | eng |
| dc.subject.keywords | Innovations in health | eng |
| dc.subject.keywords | Research | eng |
| dc.subject.keywords | Nitric oxide | eng |
| dc.subject.keywords | Nociception | eng |
| dc.subject.keywords | Inflammatory pain | eng |
| dc.subject.keywords | Neuropathic pain | eng |
| dc.subject.lemb | Medicina | spa |
| dc.subject.lemb | Ciencias de la salud | spa |
| dc.subject.lemb | Ciencias médicas | spa |
| dc.subject.proposal | Óxido nítrico | spa |
| dc.subject.proposal | Nocicepción | spa |
| dc.subject.proposal | Dolorinflamatorio | spa |
| dc.subject.proposal | Dolor neuropático | spa |
| dc.title | Óxido nítrico y dolor | spa |
| dc.title.translated | Nitric oxide and pain | eng |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.hasversion | Info:eu-repo/semantics/publishedVersion | |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Artículo | spa |
| dc.type.redcol | http://purl.org/redcol/resource_type/ART |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- 2001_Óxido_nítrico_y_dolor.pdf
- Tamaño:
- 165.01 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Articulo
